CausalSentinel

Protein Dossier — KLK8 (Kallikrein-8)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Sodium in urine 0.0218 0.00618 4.09e-04 Wald ratio 1 cis NA
Forced vital capacity (FVC) -0.0152 0.00515 0.00315 Wald ratio 1 cis NA
Diagnoses - main ICD10: I84 Haemorrhoids 0.105 0.0364 0.00373 Wald ratio 1 cis NA
Potassium in urine 0.0178 0.00637 0.00536 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) -0.0148 0.00544 0.00635 Wald ratio 1 cis NA
Body mass index (BMI) 0.0168 0.00628 0.00739 Wald ratio 1 cis NA
Non-cancer illness code self-reported: high cholesterol 0.0383 0.0164 0.0193 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.0568 0.0244 0.02 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine 0.0135 0.00601 0.0244 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pernicious anaemia -0.402 0.18 0.0256 Wald ratio 1 cis NA
Ovarian cancer -0.0856 0.044 0.0518 Wald ratio 1 cis NA
Eye problems or disorders: Cataract 0.0605 0.0324 0.0624 Wald ratio 1 cis NA
…and 53 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2834_54_1 kallikrein 8 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

28 association rows across 15 traits (26 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
KLK8/NECTIN4 protein level ratio 2e-1363 rs74705037 1 GCST90315258 no MR -> candidate analysis
KLK11/KLK8 protein level ratio 1e-1342 rs74705037 1 GCST90315254 no MR -> candidate analysis
KLK8/LY6D protein level ratio 1e-1166 rs74705037 1 GCST90315257 no MR -> candidate analysis
Circulating KLK8 levels 3e-1082 rs74705037 4 GCST90860020 no MR -> candidate analysis
Kallikrein-8 levels 4e-150 rs74705037 3 GCST90248164 no MR -> candidate analysis
Kallikrein-8 levels (KLK8.13708.56.3) 6e-58 rs74705037 3 GCST90241680 no MR -> candidate analysis
kallikrein-11 levels 2e-50 rs1122466 1 GCST90012012 no MR -> candidate analysis
Kallikrein-8 (analyte X13708.56) levels 8e-50 rs1722546 1 GCST90422316 no MR -> candidate analysis
KLK12 protein levels 5e-35 rs74705037 4 GCST90469698 no MR -> candidate analysis
KLK7 protein levels 7e-33 rs1722547 1 GCST90469706 no MR -> candidate analysis
Serum levels of protein KLK8 9e-23 rs10410942 1 GCST90088093 no MR -> candidate analysis
Blood protein levels 2e-17 rs10410942 2 GCST006585 no MR -> candidate analysis
…and 3 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 263 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
actinic keratosis 0.526 common-variant locus no MR -> candidate analysis

Of the 1 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Kallikrein-8)
gnomAD constraint pLI=7.6e-05, LOEUF=1 — LoF-tolerant
GWAS Catalog 185 unique SNPs / 442 rows
ClinVar 72 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance